New Asthma Drugs Work in the Real World

by Ed Susman: For More Info, Go Here…

Studies find treatment reduces exacerbations and steroid use.

In the real world setting, treating patients with newer anti-asthma drugs works to improve lung function-permitted reductions in steroid use and also cut exacerbations substantially, researchers reported here.

In a 5-month study in which patients diagnosed with severe eosinophilic asthma were treated with the anti-interleukin-5 agents mepolizumab (Nucala) or reslizumab (Cinqair), 80.8% of the 125 patients in the study achieved a reduction in exacerbation, reported Prerna Sharma, MD, of the University of Pittsburgh Medical Center.


Leave a Reply